Cargando…
Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19”
Autores principales: | Buonomo, Antonio Riccardo, Viceconte, Giulio, Gentile, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647515/ https://www.ncbi.nlm.nih.gov/pubmed/34872608 http://dx.doi.org/10.1186/s13054-021-03836-7 |
Ejemplares similares
-
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience
por: Gentile, Ivan, et al.
Publicado: (2021) -
Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study
por: Viceconte, Giulio, et al.
Publicado: (2023) -
COVID-19 and Pneumocystis jirovecii pneumonia: Back to the basics
por: Mouren, D., et al.
Publicado: (2021) -
Pneumocystis jirovecii Pneumonia Associated with COVID-19 in Patients with Interstitial Pneumonia
por: Takahashi, Tomoyuki, et al.
Publicado: (2022) -
Is it COVID-19? Pneumocystis jirovecii pneumonia as a differential diagnosis
por: Su, Chih-wen
Publicado: (2023)